The Scientific Board of the IBSA Foundation is made up of world-class representatives from the scientific community and academia. The Foundation avails itself of the advice of these specialists who have earned a strong international reputation for their research in the Foundation’s areas of focus.
The Board is coordinated by Silvia Misiti as Director of the IBSA Foundation for scientific research. The Board is made up of Andrea Alimonti, Head of the Molecular Oncology Laboratory of the Institute of Oncology Research in Bellinzona and of the Molecular Oncology Laboratory of the Veneto Institute of Molecular Medicine in Padova, Full Professor of Oncology at Università della Svizzera italiana, Full Professor of Pharmacology at Università degli Studi di Padova, Full Professor of Experimental Oncology and Translational Cancer Medicine at ETH Zurich; Antonio Musarò, Full Professor of Histology, Embryology and Biotechnology, Neuromuscular Research Group, Tissue Engineering Unit at the Sapienza University of Rome; Bruno Imthurn, Full Professor and Chairman, Department of Reproductive Endocrinology, University Hospital Zurich and Domenico Salvatore, Associate Professor in Endocrinology, Faculty of Medicine and Surgery at the University of Naples Federico II.
Director of IBSA Foundation for scientific research
Silvia Misiti, MD PhD, she started her career in 2001 as Assistant Professor in Endocrinology at Sapienza University of Rome.
In 2012 she moved to Lugano, where she directs the IBSA Foundation for scientific research, a non-profit organization created by the pharmaceutical company IBSA Institut Biochimique SA. Her mission is to combine the passion for scientific research with the promotion of multiple activities always focused on innovation, education and dissemination, through close contacts with the cultural and academic institutions, to keep a wide look on what research offers us today to overcome the frontier of knowledge.
She currently is, also, Head of Corporate Communication & CSR at IBSA.
Head of the Molecular Oncology Laboratory of the Institute of Oncology Research in Bellinzona and of the Molecular Oncology Laboratory of the Veneto Institute of Molecular Medicine in Padova, Full Professor of Oncology at Università della Svizzera italiana, Full Professor of Pharmacology at Università degli Studi di Padova, Full Professor of Experimental Oncology and Translational Cancer Medicine at ETH Zurich
Graduated from the Sapienza University of Rome, Andrea Alimonti completed his studies in clinical oncology at the Regina Elena National Cancer Institute, in Rome. He then continued his education in the United States, first at the Memorial Sloan-Kettering Cancer Center in New York and then at the Harvard Medical School in Boston, where he worked in the Pandolfi Laboratory, a cutting-edge cancer research institute. Prof. Alimonti is currently Head of the Molecular Oncology Laboratory of the Institute of Oncology Research – IOR (affiliated with Università della Svizzera italiana) in Bellinzona and of the Molecular Oncology Laboratory of the Veneto Institute of Molecular Medicine in Padova (affiliated with Università degli Studi di Padova), Full Professor of Oncology at Università della Svizzera italiana, of Pharmacology at Università degli Studi di Padova, and of Experimental Oncology and Translational Cancer Medicine at ETH Zurich.
His research is focused on the characterization of a novel type of cellular senescence response which is elicited by complete loss of the tumor suppressor PTEN, and on the identification of novel compounds with pro-senescence activity. His final aims are: to develop the concept of pro-senescence therapy for cancer, from experimental evidence to the clinic, investigating the efficacy of “pro-senescence” compounds in phase I clinical trials; to combine pro-senescence therapy with other drugs to enhance the anti-tumor activity of the immune system; to identify senescence markers in human tumor samples to be used clinically.
Full Professor of Histology, Embryology and Biotechnology, Neuromuscular Research Group, Tissue Engineering Unit at the Sapienza University of Rome
Antonio Musarò graduated in Biology and received his PhD in Biotechnological Sciences. He has worked as Research fellow in Medicine at Harvard University in the laboratory of Nadia Rosenthal (Cardiovascular Research Center, Massachusetts General Hospital, Boston). He received an honorary position as Adjunct Associate Professor at the Edith Cowan University, Western Australia, at the School of Biomedical & Sports Science, Faculty of Computing, Health and Science. He is currently Full Professor at the Sapienza University of Rome, Department of Anatomical Sciences, Histology, Legal Medicine and Locomotor Apparatus; Coordinator of the PhD program in Morphogenesis and tissue engineering and Director of II level Master in “Stem cells and genome editing” at Sapienza University of Rome.
He has received several prestigious awards, including the “Sapienza Ricerca 2009″ award for the six most promising scientists performing fore-front research within the whole University, the award for Scientific Communication “Foglia di Tabacco”, and La Plejade ANCIS International Award 2014 for Scientific Research.
He was Chief of the Interuniversity Institute of Myology. He is Author and Co-Author of more than 120 publications in international journals, focused on different topics in muscle biology and homeostasis. He is the Project Creator and Organizer of the Festa della Scienza, a scientific event that is held annually in Salento (Puglia). He is also involved in several activities related to science communication, such as “I ragazzi di Pasteur”, of which he is the Scientific Coordinator and Author of the first volume of the book series “I ragazzi di Pasteur”, entitled: “Stories of stem cells; from the myth of Prometheus to regenerative medicine” and Co-Author of the volume: “Transformations: how a cell goes crazy”.
Full Professor and Chairman, Department of Reproductive Endocrinology at the University Hospital Zurich
Dr. Bruno Imthurn graduated from the Faculty of Medicine at the University of Zurich, then completed his studies in Gynecological Endocrinology and Reproductive Medicine at the Endocrinology Clinic, Department of Obstetrics and Gynecology of the Zurich University Hospital. His postgraduate course continued in Melbourne, Australia, at the Monash University Institute of Reproduction and Development.
He is currently Professor and Chairman of the Department of Reproductive Endocrinology at the University of Zurich. In addition, he is the Author and Co-Author of numerous peer-reviewed scientific papers, his works have been presented at many national and international conferences. His contributions have been recognized by authoritative experts in the field all over the world. He is an active member of various societies and academies: he is Chairman of the Scientific Committee of the Swiss Society of Obstetrics and Gynecology (SGGG) and a member of the Swiss Medical Association (FMH), the Swiss Society of Reproductive Medicine (SGRM), the Swiss Society of Menopause (SMG) and the European Society for Human Reproduction and Embryology (ESHRE).
The academic career of Dr. Imthurn is studded with numerous awards and his research, focused on reproductive endocrinology, has obtained many funding.
Full Professor of Endocrinology, Department of Molecular and Clinical Endocrinology at the University of Naples Federico II
Domenico Salvatore is Full Professor of Endocrinology at the Department of Molecular and Clinical Endocrinology at the University of Naples Federico II. After studying medicine, he specialized in endocrinology with a PhD in molecular endocrinology and a specialization in clinical endocrinology at the University of Naples Federico II. His studies continued abroad, with a period of research at Brigham’s Thyroid Division Women’s Hospital, Harvard Medical School.
Professor Salvatore has collaborated with some of the most prestigious scientific journals in the field of endocrinology, including “Frontiers” in Thyroid Endocrinology, “Journal of Endocrinology” – the official journal of the English Society of Endocrinology, “Hot Thyroidology” – journal of the European Thyroid Association, “Endocrinology” – official journal of the Endocrine Society, and “Thyroid” – official journal of the American Thyroid Association. In addition, he is the Author and Co-Author of numerous scientific articles and peer-reviewed presentations, and thanks to his work has been a guest of many national and international conferences.